Background: Early diagnosis and treatment of neonatal infection is important to prevent morbidity and mortality. The gastrointestinal tract-derived hormones ghrelin and peptide YY (PYY), which participate in the regulation of food intake and energy balance, may also play roles in the inflammatory response. Their involvement in neonatal infection is not known. Methods: Plasma ghrelin and PYY(3-36) levels were serially measured (by ELISA) on Days 0, 1, 2, 3 and 7 following admission in 36-term neonates with febrile infection (22 of them were septic) and once in 20 healthy term neonates of similar postnatal age and gender distribution, as controls. Associations of ghrelin and PYY(3-36) levels with clinical and laboratory parameters, including anthropometrics, fever, leukocyte and platelet counts, serum glucose, C-reactive protein (CRP) and serum amyloid A levels, were assessed. Results: Plasma ghrelin levels were significantly higher in infected neonates than in controls at each study day (p = 0.009), whereas PYY(3-36) levels did not differ significantly between patients and controls at any day. In infected neonates, ghrelin levels on admission correlated negatively with serum glucose levels (p = 0.003), whereas fever change during the course of infection was significantly associated with change of ghrelin levels (p = 0.01). Receiver operating characteristic analysis of ghrelin levels
Introduction
Infections remain one of the leading causes of morbidity and mortality in neonatal age and may also have severe long-term consequences [1] . Infants who have suffered neonatal sepsis face an increased risk for brain damage and neurodevelopmental delays [2, 3] , whereas, experimental data have shown that inflammation/infection early in life may alter the developmental trajectory of the immune system and the brain [4, 5] . Early diagnosis and management of neonatal infection improves prognosis; thus, the identification of new or complementary biomarkers of neonatal infection or sepsis is of potential importance [6] .
Ghrelin and peptide YY (PYY) , one of the two major molecular forms of total PYY -the other isoform being PYY(1-36)-, are gastrointestinal tract-derived hormones that play roles in the regulation of food intake and energy balance with opposite effects; ghrelin is orexigenic, whereas PYY(3-36) suppresses food intake [7, 8] . Furthermore, studies in animals and human adults have clearly shown that ghrelin has additional properties; among others, ghrelin is implicated in systemic inflammation [9] . Circulating ghrelin is one of the first hormones that rapidly increase in the human adult physiological response to bacterial endotoxin [10] . Interestingly, ghrelin administration has beneficial effects in septic animal models. Treatment with ghrelin decreased proinflammatory cytokines and gut-derived norepinephrine release [11, 12] , improved organ blood flow by inhibiting nuclear factor-κ B [13] , corrected, at least partially, the abnormalities of hemodynamic and metabolic disturbances and maintained cardiovascular stability [14, 15] , ameliorated gut barrier dysfunction [16] , protected against endotoxemia-induced acute kidney injury [17] and also reduced the endotoxin-induced shock and the mortality rate [18] . Ghrelin has not been studied in neonates with infection or sepsis as yet.
It is not known whether PYY is implicated in the inflammatory response. There is only some knowledge relevant to total PYY; animal studies have shown increased circulating levels of total PYY during sepsis [19] , whereas sepsis stimulated PYY production in isolated rat enterocytes [20] . In adult humans, mRNA of total PYY was expressed in peripheral blood mononuclear cells [21] . However, contrary to studies in animals, treatment of human monocytic THP-1 cells with lipopolysaccharide, in vitro, caused down-regulation of PYY mRNA levels [21] .
The objective of this study was to evaluate plasma ghrelin and PYY(3-36) levels and their possible alterations during neonatal infection, and to examine the clinical value of ghrelin or PYY(3-36) as biomarkers of neonatal infection. As reduced food intake is often one of the presenting symptoms of infection in term infants, we selected to measure PYY(3-36) instead of the total PYY due to its more potent relevant action in comparison with the other isoform PYY(1-36) [22] .
Materials and methods

Subjects and study protocol
The study population consisted of 36 term Greek Caucasian neonates (mean±SD gestational age 38.8±1.0 weeks; birthweight 3.037±389 g; male/female 21/15) admitted to our Special Care (Level II) Neonatal Unit from the emergency department, at 17.0±5.0 days of life, due to febrile infection, and 20 healthy term Greek neonates, as controls. The group of controls consisted of infants admitted to our unit after birth and subsequently followed up at our outpatient clinic. In controls, gestational age (38.8±1.0 weeks), birthweight (3.187±370 g), postnatal age (15.6±6.3 days) and gender distribution (male/female 12/8), did not differ significantly from those in the group of neonates with infection. Infants with prematurity, congenital malformations, perinatal asphyxia, previous antibiotic treatment, surgery, or age ≤ 3 days, were excluded. Twenty-two out of 36 infected neonates were septic. Sepsis was defined according to the criteria established by the international pediatric sepsis consensus conference [23] ; evidence of systemic inflammatory response syndrome (SIRS) in the presence of or as a result of suspected or proven infection was required [23] .
On admission, all febrile neonates underwent blood, cerebrospinal fluid (CSF), and suprapubic urine sampling for analyses and cultures; plasma was isolated within 30 min and stored at −80 °C for measurement of plasma ghrelin and PYY levels. Blood samples were also drawn serially, before feeding, from all infected infants at 1, 2, 3 and 7 days following admission for routine blood tests, as well as for plasma isolation and storing at −80 °C for ghrelin and PYY(3-36) levels determination. Blood was obtained only once from controls. In all infants studied, associations of ghrelin and PYY(3-36) levels with clinical and laboratory parameters, including anthropometrics, fever, leukocyte and platelet counts, blood biochemistry for glucose levels, renal and liver function, and serum C-reactive protein (CRP) were assessed. Moreover, associations of ghrelin and PYY(3-36) levels on admission and at Day 1 with serum levels of amyloid A (SAA), having been shown to be a marker with high sensitivity in the first 2 days of sepsis symptoms in newborns [24] , were examined. All patients were initially treated with antibiotics intravenously after blood, urine and CSF cultures had been obtained; antibiotic treatment was discontinued in cases with no clinical sepsis, white blood cells (WBC) count and differential within normal range [14] and serum CRP values < 10 mg/L on admission and 24 h later, and negative cultures.
The type of infection was bacterial in all septic neonates confirmed only by blood culture in six (E.coli; 4, Klebsiella; 2), urine culture in 11 (E.coli; 9, Klebsiella; 2), or by both blood/urine culture in four (E.coli; 3, enterococcus; 1) and blood/CSF culture in one neonate (Streptococcus agalactiae). Infections were probably viral in the 14 non-septic neonates; cultures were negative and WBC count and differential were within normal range in all of them, whereas serum CRP levels were < 10 mg/L in 13/14. In the remaining one out of 14 nonseptic neonates, CRP levels were 12 mg/L.
The "Aghia Sophia" Children's Hospital Ethics Committee approved the study and informed parental consent was also obtained.
Assays
Hematologic parameters were measured using a Siemens-ADVIA 120 whole blood auto-analyzer (Siemens Healthcare Diagnostics, Tarrytown, NY, USA). Blood Chemistry for glucose levels, renal and liver function was performed using the Siemens Advia 1800 Clinical Chemistry System (Siemens Healthcare Diagnostics). Serum CRP concentrations were determined with immunonephelometry using a Beckman Coulter IMMAGE immunochemistry system (Beckman Coulter, Inc. Fullerton, CA, USA). The intra-and inter-assay coefficients of variation (CVs) of CRP measurements were 3.5% and 7.0%, respectively. SAA levels were determined by particle-enhanced immunonephelometry using the BN ProSpec System (Siemens Healthcare Diagnostics, Liederbach, Germany). The intra-and inter-assay CVs of SAA measurements were 4.3%-6.2% and 2.8%-4.7%, respectively, and the sensitivity limit 3.5 mg/L.
For ghrelin and PYY(3-36) determination, plasma was isolated from EDTA-K 3 anticoagulated blood samples of neonates following centrifugation at 1600 g at 4 °C for 15 min and stored at −80 °C until analysis. Plasma ghrelin and PYY(3-36) levels were determined using commercial Enzyme Immunoassay kits (Ghrelin Human EIA Kit Extraction Free and Peptide YY(3-36) Human EIA Kit Extraction Free, respectively, Phoenix Pharmaceuticals, Inc.). These Enzyme Immunoassay kits are designed to detect specific peptides based on the principle of "competitive" enzyme immunoassay. The intra-and inter-assay CVs for ghrelin were < 5% and 14%, respectively, whereas the intra-and inter-assay CVs for PYY were < 10% and 15%, respectively. The sensitivity limit was 0.13 ng/mL for ghrelin and 0.06 ng/mL for PYY .
Statistical analyses
The minimum sample size of the study was calculated using our previous report of circulating ghrelin and PYY concentrations in healthy full-term infants [25] . Assuming an α risk of 0.05, a power of 0.80, and a bilateral test, it was estimated that approximately 10 neonates was the minimum number of infants needed in each group to detect a significant difference of one SD in mean ghrelin or PYY levels between infected and healthy infants.
Data are presented as mean±SD, unless otherwise noted. On Day 0 (at admission/baseline), values of ghrelin and PYY(3-36) were not normally distributed overall (Kolmogorov-Smirnov test), but the distribution was normal for neonates with infection and controls, separately. Comparisons of quantitative variables between more than two groups were conducted by ANOVA with Bonferoni post hoc analysis or by Kruskal-Wallis and Mann-Whitney U-test, as appropriate. One-way repeated measures ANOVA was used to further analyze serial measurements of ghrelin and PYY . Correlation (Pearson's or Spearman's correlation test, as appropriate) and regression analyses were used to examine relations among the variables of interest. The diagnostic properties of ghrelin and PYY(3-36) concentrations were assessed by receiver operating characteristic (ROC) analysis.
Levels of statistical significance were set at p ≤ 0.05. All statistical analyses were performed using the SPSS statistical package (SPSS, version 19.0, Chicago, IL, USA).
Results
On admission (Day 0)
Demographic, anthropometric, clinical characteristics, and laboratory findings, including total WBC, absolute neutrophil count (ANC), platelet count, serum glucose, liver, renal biochemistry, CRP, and SAA levels, in the total group of neonates with infection, and in septic and nonseptic group of infants, separately, on admission to the unit, as well as in controls, are shown in Table 1 . WBC, ANC, serum urea, CRP and SAA values, were significantly higher, whereas body weight and weight gain since birth were significantly lower in the group of septic infants in comparison with the non-septic one; gestational and postnatal age, gender, fever characteristics, or other variables studied did not differ significantly between septic and non-septic infants (Table 1) .
Mean±SD plasma ghrelin levels, on admission, were significantly higher in the entire group of infected neonates (2.14±0.98 ng/mL) in comparison with controls (1.42±0.97 ng/mL; p = 0.01). Ghrelin levels were also higher in septic (2.28±1.14 ng/mL) and non-septic neonates (1.94±0.59 ng/mL), separately, than in controls (p = 0.01 and p = 0.02, respectively) ( Figure 1A) . No difference was recorded in ghrelin levels, on admission, between septic and non-septic neonates (p = 0.84) ( Figure 1A ).
Mean±SD plasma PYY(3-36) levels on admission did not differ significantly between the entire population of infected neonates (1.02±0.82 ng/mL) and controls (0.84±0.49 ng/mL). Also, no difference was observed in PYY levels between septic and non-septic neonates on admission, and controls (Figure 2A ).
In the entire study population, baseline ghrelin levels correlated significantly with total WBC (r s = 0.31, p = 0.02), SAA (r s = 0.34, p = 0.01) and serum glucose concentrations (r s = −0.51, p < 0.001; Figure 3 ), but not with other variables including gestational or postnatal age, anthropometric parameters, ANC, liver or renal function, CRP and PYY(3-36) levels. The correlation between ghrelin and glucose levels was observed in both neonates with infection (r s = −0.48, p = 0.003) and controls (r s = −0.43, p < 0.05) ( Figure 3 ). On the contrary, the correlation between ghrelin and WBC, as well as between ghrelin and SAA, in neonates with infection was not significant. Plasma PYY(3-36) levels correlated significantly with ghrelin levels only in controls (r = 0.43, p < 0.05). Figure 4A ). In our study population, ghrelin values > 1.40 ng/mL on admission could detect infection with sensitivity 75%, specificity 70%, positive predictive value (PPV) 82% and negative predictive value (NPV) 61%. Additionally, we evaluated whether ghrelin had a higher diagnostic accuracy for infection or for discrimination between septic and non-septic infected neonates on admission when combined with the other measured markers of infection ( Table 2 ( Figure 4B ) than CRP, SAA, WBC and ANC, respectively, on admission.
Diagnostic value of ghrelin levels on admission
Serial measurements of ghrelin and PYY(3-36) levels in neonates with infection
Serial measurements of plasma ghrelin levels in the total group of infected neonates were significantly higher than in controls by one-way repeated measures ANOVA (F = 7.52, p = 0.009) at each study day ( Figure 1B) , whereas PYY(3-36) levels did not differ significantly between patients and controls at any study day ( Figure 2B ). The time points at which repeat blood samples were obtained did not have any significant effect on plasma ghrelin levels (F = 0.31, p = 0.73; Figure 1B) ; moreover, the effect of the infection type (sepsis or non-sepsis) was not significant (F = 2.35, p = 0.15) ( Figure 1C) . Interestingly, the duration of fever following admission was significantly associated with change in ghrelin levels on serial measurements (F = 7.55, p = 0.01). In the group of infants whose fever subsided within 36 h following admission to the Neonatal Unit (n = 20; 10 septic and 10 non-septic neonates), ghrelin concentrations decreased significantly at 24 and 48 h after admission (study day 1 and 2, respectively) in comparison with baseline (p = 0.001 and p = 0.008, respectively) ( Figure  1D ). On the contrary, in the group of infants who were febrile for more than 36 h following admission (n = 16; 12 septic and 4 non-septic neonates), ghrelin levels further increased after admission ( Figure 1D ).
Plasma PYY(3-36) levels did not differ significantly between septic and non-septic neonates on serial measurements ( Figure 2C) . Moreover, the change of fever during the course of infection did not have any significant effect on plasma PYY(3-36) levels.
Correlations of ghrelin with markers of infection during the infection period
We examined whether ghrelin correlates better with markers of infection later during the infection period following admission. On Day 1, ghrelin levels in neonates 
Discussion
This is the first study evaluating circulating ghrelin concentrations on admission and during hospitalization in neonates with infection. The majority of studies assessing the implication of ghrelin in infection/sepsis have been conducted in animals [13, [16] [17] [18] 26] . A few studies have been performed in adults [27] [28] [29] and in none of them ghrelin concentrations were evaluated serially in the course of disease. Discrepancies in the profile of circulating ghrelin levels at the acute phase of infection/sepsis were observed in previous studies in animals and adults; thus both increased [18, [26] [27] [28] and decreased levels [29, 30] have been reported. In our study, ghrelin levels were increased at the acute phase of neonatal infection, with no difference between septic and non-septic infants, in accordance with the results of the largest relevant study published in human adults [27] . Ghrelin levels were almost four times higher in neonates with infection than those reported in septic adults (median value 18.4 pmol/L [27] which is converted to 0.062 ng/mL by the formula: ghrelin concentration in pmol/L = pg/mL × 0.296), probably in the context of the physiologically increased levels of ghrelin during neonatal age [31] . Indeed, ghrelin concentrations in our control group of neonates were also approximately four times higher than levels in healthy adults (median 9.6 pmol/L; 0.032 ng/mL) [27] .
The pathophysiologic mechanisms leading to ghrelin level alterations at the acute phase of infection are not known. Participation of IL-1 and prostaglandin pathways, TNF-α and IL-6, gastric cells' toll-like receptor 4, and vagal nerve mediation, have all been proposed [10, 28, 30, 32] . A significant correlation between ghrelin and inflammatory cytokines or CRP were reported in a few studies [26, 28] , but not in others [27] . Also in our study, ghrelin levels on admission did not correlate with common markers of infection, including CRP or SAA levels, WBC, and neutrophil count in neonates with infection; we only observed correlations of ghrelin with WBC and SAA levels in the entire study population. However, it was found that ghrelin correlated with CRP, SAA and ANC later during the infection period. The lack of measurements of pro/antiinflammatory cytokines is a limitation of our study.
The absence of a consistent significant correlation between ghrelin and markers of infection in our study population can possibly be attributed to the complex mechanisms regulating ghrelin production/release. Several factors, including nutrients, caloric intake and energy status, a number of hormones (e.g., insulin, leptin, cortisol, gastrin, cholecystokinin, growth hormone), and neural activities can influence circulating ghrelin levels in vivo [33] . The negative correlation between ghrelin and glucose in both our patients and controls can be explained by the fact that ghrelin is involved in maintaining glucose homeostasis in health and disease [34] .
A significant association was found between fever duration and change in ghrelin levels in our study population. Whereas ghrelin levels further increased, in comparison with baseline, in infants who were febrile for more than 36 h following admission, ghrelin concentrations decreased in the group of infants whose fever subsided within 36 h and reached a nadir level at 48 h, which was similar to levels in controls ( Figure 1D ). The association between fever and ghrelin might be attributed to an influence of fever, and the associated with fever mediators, e.g., cytokines, on ghrelin production/release [10, 28] . Inversely, an anti-inflammatory/antipyretic role of ghrelin cannot be excluded. The anti-inflammatory role of ghrelin has been clearly previously shown in animals [14] , whereas it was also shown recently that ghrelin controls the thermoregulatory system acting as an antipyretic molecule [35] . Exogenous ghrelin attenuated endotoxin fever in rats by stimulating corticosterone secretion and, also, by reducing directly the prostaglandin E2 production in the preoptic region [35] .
This study also showed that ghrelin has a significant clinical value as a diagnostic marker of infection in term neonates. Experimental studies have recognized ghrelin as an acute phase reactant in animal models of the inflammatory reaction [28] . In humans, ghrelin was one of the first hormones rapidly increasing within 2 h after bacterial endotoxin administration; its peak occurred 30 min after the TNF-α peak and corresponded with the peak level of IL-6, IL-1 receptor antagonist, growth hormone and adrenocorticotropic hormone (ACTH) [10] . However, the clinical value of ghrelin as a diagnostic marker of infection in our study population was not stronger than that of the other markers of infection studied; amyloid was confirmed as a promising diagnostic marker of neonatal infection [24] , whereas CRP, WBC and ANC values on admission had greater diagnostic performance not only in comparison with ghrelin, but also compared with their diagnostic performance in previous studies [36] . The latter can be attributed to differences in the characteristics of populations studied; as we focused on the evaluation of the utility of ghrelin as a diagnostic marker in comparison with routinely used markers of infection, our study population was composed of neonates who could be clearly categorized as septic (with all of them suffering from serious febrile bacterial infections with positive markers of inflammation) or infected but not septic. Interestingly, specificity and PPV of ghrelin levels for the diagnosis of infection on admission were increased when ghrelin was combined with CRP, SAA, WBC or ANC (Table 2) . Also, specificity, PPV and NPV of ghrelin levels for discrimination between septic and non-septic infected neonates on admission were improved when ghrelin was combined with CRP, SAA, WBC or ANC. Whether ghrelin alone or in combination with other markers could also have a prognostic value in neonatal infection cannot be answered by this study as all neonates with infection were hospitalized in a special (Level II), but not intensive, care unit and the course of disease was neither complicated nor fulminant in any of them.
In comparison with ghrelin, the implication of PYY in infection/inflammation has been much less studied with researchers focusing only on total PYY but not on PYY . Increased total PYY concentrations were reported in blood and isolated enterocytes in animal models of sepsis [19, 20] . As it regards humans, it is only known that treatment of human monocytic THP-1 cells with bacterial endotoxin, in vitro, caused down-regulation of total PYY mRNA levels [21] . In our study, only PYY(3-36), but not total PYY, was determined. We did not find any association of PYY(3-36) levels with neonatal infection.
In conclusion, circulating ghrelin, but not PYY , levels are elevated in term neonates with infection. Ghrelin levels on admission correlated negatively with serum glucose levels, whereas fever change during the course of infection was significantly associated with change of ghrelin levels. Whether the above are also valid in preterm infants with infection or sepsis is not known. Further studies are needed to evaluate the precise role of ghrelin in neonatal infection.
